Integer Q1 sales up 10% to $415M, adjusted EPS $1.14; reiterates FY2024 outlook

Integer Holdings Corp

2024-Q1 EPS reported $0.59 revenue$414,805,000

Sales of $415M (+10% YoY), organic growth 6%; GAAP net income $21M (+57%), diluted EPS $0.59.
Non-GAAP adjusted net income $39M (+33%), adjusted EPS $1.14 vs $0.87; adjusted EBITDA $81M (+22%).
Total debt $1.141B (up $181M) to finance Pulse acquisition; leverage ratio 3.4x adjusted EBITDA.
Cardio & Vascular sales +16%; Cardiac Rhythm & Neuromodulation +8%; Electrochem declined.
FY2024 outlook reaffirmed: sales $1.735-1.770B (9-11% growth), adjusted EPS $5.01-$5.43.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Integer Holdings Corp reported the first quarter ended March 29, 2024 results: revenue $415 million, net income $21 million, EPS $0.59 per share. Guidance reaffirmed.

Period: the first quarter ended March 29, 2024
Revenue: $415 million
Net income: $21 million
EPS: $0.59 per share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

today announced results for the three months ended March 29, 2024. First Quarter 2024 Highlights (compared to First Quarter 2023, except as noted) Sales increased 10% to $415 million, with organic growth of 6%. GAAP net income increased $7 million to $21 million, an increase of 57%. Non-GAAP adjusted net income increased $10 million to $39 million, an

View on SEC.gov

1428 earnings releases filed in the last 30 days. Browse all earnings releases →

Integer Holdings Corp filing history →

Source: SEC EDGAR

accession 0001171843-24-002222

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.